Estrogenic action on arterial smooth muscle: Permissive for maintenance of CRHR2 expression

Endocrinology

Volumn 153, Issue 4, 2012, Pages 1915-1924

  Wang, Shan ^a   Zhu, Xiaoyan ^a   Cong, Binhai ^a   You, Xingji ^a   Wang, Yangkai ^a   Wang, Weizhong ^a   Ni, Xin ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; ESTRADIOL; ESTROGEN RECEPTOR BETA; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; INOSITOL 1,4,5 TRISPHOSPHATE; PHENYLEPHRINE; PHOSPHOLIPASE C BETA3; UNCLASSIFIED DRUG; UROCORTIN; UROCORTIN RECEPTOR TYPE 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTERY MUSCLE; ARTICLE; CALCIUM SIGNALING; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; FEMALE; IN VITRO STUDY; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SHAM PROCEDURE; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ANIMALS; AORTA, THORACIC; CALCIUM SIGNALING; CELLS, CULTURED; ESTRADIOL; ESTROGEN RECEPTOR BETA; ESTROGENS; FEMALE; MODELS, ANIMAL; MUSCLE, SMOOTH, VASCULAR; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SIGNAL TRANSDUCTION; UROCORTINS; VASODILATION;

EID: 84859391785     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2011-1939     Document Type: Article

References (50)

1. Mendelsohn ME, Karas RH 2005 Molecular and cellular basis of cardiovascular gender differences. Science 308:1583-1587 (Pubitemid 40807497)
2. Gerhard M, Ganz P 1995 How do we explain the clinical benefits of estrogen? From bedside to bench. Circulation 92:5-8
3. Tolbert T, Oparil S 2001 Cardiovascular effects of estrogen. Am J Hypertens 14:186S-193S (Pubitemid 32506714)
4. Mendoza SG, Zerpa A, Carrasco H, Colmenares O, Rangel A, Gartside PS, Kashyap ML 1983 Estradiol, testosterone, apolipoproteins, lipoprotein cholesterol, and lipolytic enzymes in men with premature myocardial infarction and angiographically assessed coronary occlusion. Artery 12:1-23 (Pubitemid 14123137)
5. Dantas AP, Tostes RC, Fortes ZB, Costa SG, Nigro D, Carvalho MH 2002 In vivo evidence for antioxidant potential of estrogen in microvessels of female spontaneously hypertensive rats. Hypertension 39:405-411 (Pubitemid 34165157)
6. Zegura B, Keber I, Sebestjen M, Koenig W 2003 Double blind, randomized study of estradiol replacement therapy on markers of inflammation, coagulation and fibrinolysis. Atherosclerosis 168: 123-129 (Pubitemid 36555819)
7. Miller VM, Duckles SP 2008 Vascular actions of estrogens: functional implications. Pharmacol Rev 60:210-241 (Pubitemid 351962010)
8. Koh KK 2002 Effects of estrogen on the vascular wall: vasomotor function and inflammation. Cardiovasc Res 55:714-726
9. Watanabe T, Akishita M, Nakaoka T, Kozaki K, Miyahara Y, He H, Ohike Y, Ogita T, Inoue S, Muramatsu M, Yamashita N, Ouchi Y 2003 Estrogen receptor β mediates the inhibitory effect of estradiol on vascular smooth muscle cell proliferation. Cardiovasc Res 59:734-744 (Pubitemid 38368690)
10. Castillo C, Ceballos G, Rodríguez D, Villanueva C, Medina R, López J, Méndez E, Castillo EF 2006 Effects of estradiol on phenylephrine contractility associated with intracellular calcium release in rat aorta. Am J Physiol Cell Physiol 291:C1388-C1394 (Pubitemid 44878610)
11. Donaldson CJ, Sutton SW, Perrin MH, Corrigan AZ, Lewis KA, Rivier JE, Vaughan JM, Vale WW 1996 Cloning and characterization of human urocortin. Endocrinology 137:3896
12. Ikeda K, Tojo K, Sato S, Ebisawa T, Tokudome G, Hosoya T, Harada M, Nakagawa O, Nakao K 1998 Urocortin, a newly identified corticotropin-releasing factor-related mammalian peptide, stimulates atrial natriuretic peptide and brain natriuretic peptide secretions from neonatal rat cardiomyocytes. Biochem Biophys Res Commun 250:298-304 (Pubitemid 28463872)
13. Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, Rivier C, et al 1995 Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin- releasing factor. Nature 378:287-292
14. Okosi A, Brar BK, Chan M, D'Souza L, Smith E, Stephanou A, Latchman DS, Chowdrey HS, Knight RA 1998 Expression and protective effects of urocortin in cardiac myocytes. Neuropeptides 32: 167-171 (Pubitemid 28212540)
15. Bamberger CM, Wald M, Bamberger AM, Ergün S, Beil FU, Schulte HM 1998 Human lymphocytes produce urocortin, but not corticotropin- releasing hormone. J Clin Endocrinol Metab 83:708-711 (Pubitemid 28496563)
16. Lubomirov L, Gagov H, Petkova-Kirova P, Duridanova D, Kalentchuk VU, Schubert R 2001 Urocortin relaxes rat tail arteries by a PKA-mediated reduction of the sensitivity of the contractile apparatus for calcium. Br J Pharmacol 134:1564-1570 (Pubitemid 33131908)
17. Schilling L, Kanzler C, Schmiedek P, Ehrenreich H 1998 Characterization of the relaxant action of urocortin, a new peptide related to corticotropin-releasing factor in the rat isolated basilar artery. Br J Pharmacol 125:1164-1171 (Pubitemid 28542523)
18. + channels in endothelium- independent relaxation by urocortin in the rat coronary artery. Cardiovasc Res 57:824-833
19. Seçilmi MA, Ozü OY, Emre M, Büyükafar K, Kiroglu OE, Ertu P, Karata Y, Onder S, Singirik E 2007 Urocortin induces endothelium-dependent vasodilatation and hyperpolarization of rat mesenteric arteries by activating Ca2+-activated K+ channels. Tohoku J Exp Med 213:89-98 (Pubitemid 47516905)
20. Miki I, Seya K, Motomura S, Furukawa K 2004 Role of corticotropin- releasing factor receptor type 2β in urocortin-induced vasodilation of rat aortas. J Pharmacol Sci 96:170-176 (Pubitemid 39469608)
21. Leitch IM, Boura AL, Botti C, Read MA, Walters WA, Smith R 1998 Vasodilator actions of urocortin and related peptides in the human perfused placenta in vitro. J Clin Endocrinol Metab 83:4510-4513 (Pubitemid 29100159)
22. Vale W, Vaughan J, Perrin M 1997 Corticotropin-releasing factor (CRF) family ligands and their receptors. Endocrinologist 7:3S-9S (Pubitemid 27091918)
23. Brar BK, Stephanou A, Okosi A, Lawrence KM, Knight RA, Marber MS, Latchman DS 1999 CRH-like peptides protect cardiac myocytes from lethal ischaemic injury. Mol Cell Endocrinol 158:55-63
24. Knight RA, Chen-Scarabelli C, Yuan Z, McCauley RB, Di Rezze J, Scarabelli GM, Townsend PA, Latchman D, Saravolatz L, Faggian G, Mazzucco A, Chowdrey HS, Stephanou A, Scarabelli TM 2008 Cardiac release of urocortin precedes the occurrence of irreversible myocardial damage in the rat heart exposed to ischemia/reperfusion injury. FEBS Lett 582:984-990
25. Clifton VL, Crompton R, Smith R, Wright IM 2002 Microvascular effects of CRH in human skin vary in relation to gender. J Clin Endocrinol Metab 87:267-270 (Pubitemid 34086939)
26. Clifton VL, Crompton R, Read MA, Gibson PG, Smith R, Wright IM 2005 Microvascular effects of corticotropin-releasing hormone in human skin vary in relation to estrogen concentration during the menstrual cycle. J Endocrinol 186:69-76 (Pubitemid 41015665)
27. Haeger P, Andrés ME, Forray MI, Daza C, Araneda S, Gysling K 2006 Estrogen receptors α and β differentially regulate the transcriptional activity of the urocortin gene. J Neurosci 26:4908-4916 (Pubitemid 44315332)
28. Zhu X, Liu X, He P, Cao B, Lv Y, Zhang W, Ni X 2010 Metabolomics in serum of ovariectomised rats and those exposed to 17β- oestradiol and genistein. Gynecol Endocrinol 26:760-767
29. Cheng WP, Hung HF, Wang BW, Shyu KG 2008 The molecular regulation of GADD153 in apoptosis of cultured vascular smooth muscle cells by cyclic mechanical stretch. Cardiovasc Res 77:551-559
30. Liu S, Zhu X, Liu Y, Wang C, Wang S, Tang X, Ni X 2011 Endotoxin tolerance of adrenal gland: attenuation of corticosterone production in response to lipopolysaccharide and adrenocorticotropic hormone. Crit Care Med 39:518-526
31. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, Vandesompele J, Wittwer CT 2009 The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55:611-622
32. Livak KJ, Schmittgen TD 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 25:402-408 (Pubitemid 34164012)
33. Huang Y, Chan FL, Lau CW, Tsang SY, He GW, Chen ZY, Yao X 2002 Urocortin-induced endothelium-dependent relaxation of rat coronary artery: role of nitric oxide and K+ channels. Br J Pharmacol 135:1467-1476 (Pubitemid 34270918)
34. Sanchez RL, Reddy AP, Bethea CL 2010 Ovarian steroid regulation of the midbrain corticotropin releasing factor and urocortin systems in macaques. Neuroscience 171:893-909
35. Torricelli M, De Falco G, Florio P, Rossi M, Leucci E, Viganò P, Leoncini L, Petraglia F 2007 Secretory endometrium highly expresses urocortin messenger RNA and peptide: possible role in the decidualization process. Hum Reprod 22:92-96 (Pubitemid 44942670)
36. Carroll JS, Brown M 2006 Estrogen receptor target gene: an evolving concept. Mol Endocrinol 20:1707-1714 (Pubitemid 44148078)
37. Tang X, Zhu X, Liu S, Wang S, Ni X 2011 Isoflavones suppress cyclic adenosine 3′,5′-monophosphate regulatory element-mediated transcription in osteoblastic cell line. J Nutr Biochem 22:865-873
38. Catalano RD, Kyriakou T, Chen J, Easton A, Hillhouse EW 2003 Regulation of corticotropin-releasing hormone type 2 receptors by multiple promoters and alternative splicing: identification of multiple splice variants. Mol Endocrinol 17:395-410 (Pubitemid 36315634)
39. Safe S 2001 Transcriptional activation of genes by 17β-estradiol through estrogen receptor-Sp1 interactions. Vitam Horm 62:231-252 (Pubitemid 33805706)
40. Andersson C, Lydrup ML, Fernö M, Idvall I, Gustafsson J, Nilsson BO 2001 Immunocytochemical demonstration of oestrogen receptor beta in blood vessels of the female rat. J Endocrinol 169:241-247 (Pubitemid 32451657)
41. Hodges YK, Tung L, Yan XD, Graham JD, Horwitz KB, Horwitz LD2000 Estrogen receptors α and β: prevalence of estrogen receptor β mRNA in human vascular smooth muscle and transcriptional effects. Circulation 101:1792-1798 (Pubitemid 30213100)
42. Bolego C, Cignarella A, Sanvito P, Pelosi V, Pellegatta F, Puglisi L, Pinna C 2005 The acute estrogenic dilation of rat aorta is mediated solely by selective estrogen receptor-α agonists and is abolished by estrogen deprivation. J Pharmacol Exp Ther 313:1203-1208 (Pubitemid 40727023)
43. Bolego C, Vegeto E, Pinna C, Maggi A, Cignarella A 2006 Selective agonists of estrogen receptor isoforms: new perspectives for cardiovascular disease. Arterioscler Thromb Vasc Biol 26:2192-2199 (Pubitemid 44465711)
44. Kageyama K, Gaudriault GE, Suda T, Vale WW 2003 Regulation of corticotropin-releasing factor receptor type 2β mRNA via cyclic AMP pathway in A7r5 aortic smooth muscle cells. Cell Signal 15: 17-25 (Pubitemid 35223625)
45. Kageyama K, Hanada K, Suda T 2005 Regulation of corticotropin-releasing factor receptor type 2β mRNA by mitogen-activated protein kinases in aortic smooth muscle cells. Regul Pept 126:223-231 (Pubitemid 40128187)
46. Kageyama K, Gaudriault GE, Bradbury MJ, Vale WW 2000 Regulation of corticotropin-releasing factor receptor type 2β messenger ribonucleic acid in the rat cardiovascular system by urocortin, glucocorticoids, and cytokines. Endocrinology 141:2285-2293 (Pubitemid 32269046)
47. Jackson WF 2000 Ion channels and vascular tone. Hypertension 35:173-178 (Pubitemid 30054169)
48. Docherty JR 1998 Subtypes of functional α1- and α2-adrenoceptors. Eur J Pharmacol 361:1-15
49. Sanborn BM, Ku CY, Shlykov S, Babich L 2005 Molecular signaling through G-protein-coupled receptors and the control of intracellular calcium in myometrium. J Soc Gynecol Investig 12:479-487 (Pubitemid 41395236)
50. Xing D, Nozell S, Chen YF, Hage F, Oparil S 2009 Estrogen and mechanisms of vascular protection. Arterioscler Thromb Vasc Biol 29:289-295